8-KOther EventsExhibits & Filings

Dell Technologies Inc. 8-K Report, Corporate Update (Oct 19, 2021)

Filed October 19, 2021For Securities:DELL

Summary

Dell Technologies Inc. (DELL) has filed an 8-K report announcing a significant step in its previously disclosed spin-off of VMware, Inc. (VMware). The company's board of directors has officially approved the distribution of VMware shares held by Dell to Dell's common stockholders. This distribution is a key event for Dell shareholders, as it directly impacts their ownership stake in the newly independent VMware. The record date for determining eligible shareholders is set for October 29, 2021, with the distribution expected to be completed on November 1, 2021, contingent on certain closing conditions being met. This development is crucial for investors as it crystallizes the separation of the two entities, allowing Dell to focus on its core infrastructure and PC businesses while shareholders receive direct value from the VMware assets. Investors should pay close attention to the satisfaction of closing conditions and the ultimate completion of the distribution, as it marks the culmination of a strategic move intended to unlock value for both companies. The filing also includes a standard cautionary statement regarding forward-looking statements, highlighting various risks and uncertainties that could affect the completion and outcome of the transaction.

Key Highlights

  • 1Dell's Board of Directors has unanimously approved the distribution of VMware shares to Dell common stockholders.
  • 2The record date for determining eligible shareholders is October 29, 2021.
  • 3The spin-off distribution of VMware shares is expected to be completed on November 1, 2021.
  • 4The transaction is contingent upon the satisfaction of certain conditions outlined in the definitive transaction agreements.
  • 5The filing includes a cautionary statement about forward-looking statements and associated risks, uncertainties, and factors that could impact the transaction.
  • 6A press release detailing this approval and the distribution timeline is attached as an exhibit.

Frequently Asked Questions